This is an extra bulletin from the IBTA to share important news. Find out more about us at www.theibta.org

Can't read this email?
View it in your browser

IBTA e-Bulletin

Special announcement from the
International Brain Tumour Alliance
Thursday 4th November 2021

“Brilliance!” - the IBTA’s first virtual art exhibition launches to mark International Brain Tumour Awareness Week 2021

The IBTA is thrilled to announce the launch of its first virtual art exhibition of creative works from the global brain tumour community.

Brain tumour patients, family members and healthcare professionals from around the world were invited to submit up to three created pieces to “Brilliance!” together with a short explanatory text describing their artworks and how they, themselves, have been affected by a brain tumour.

In response to our invitation, we received a large number of incredible creations which shine a light on the uniqueness of our international brain tumour community and reflect a broad range of artistic media, cultures and geographic regions.

The “Brilliance!” exhibition catalogue is now available to view online and will remain available for viewing indefinitely as a tribute to the determination and resilience of our international brain tumour community and as a symbol of hope and inspiration for all.

Visit the IBTA’s “Brilliance!” virtual art exhibition catalogue here To best appreciate the submitted artworks, the catalogue should be viewed in “full screen mode”.

Facebook

Twitter

IBTA Website

ABOUT THE IBTA

Who we are

The International Brain Tumour Alliance was established in 2005. It is a network of support, advocacy and information groups representing brain tumour patients and carers in different countries and also includes researchers, scientists, clinicians and allied health professionals who work in the field of brain tumours.
For more information, please visit www.theibta.org.

Tell us what you think!

We love to hear from you if you have any news that you would like to share with the IBTA community. Just send us an email: chair@theibta.org.
We will do our best to relay as much information as possible to our subscribers via this monthly newsletter and our website. The selection of e-News entries is at the sole discretion of the editors.

Disclaimer

The International Brain Tumour Alliance (IBTA) makes every effort to be accurate regarding the information contained in this e-News (or in any documents, reports, notes or other material produced for and on behalf of the IBTA to which we provide a link in this e-News). However, the IBTA accepts no liability for any inaccuracies or omissions herein nor can it accept liability for any loss or damage resulting from any inaccuracy in this information or third party information such as information on websites to which we link. The information contained in this e-News is for educational purposes only and should in no way be taken as a substitute for medical care nor is the information on the IBTA website meant to constitute medical advice or professional services. For medical care and advice, please contact your doctor. Inclusion of clinical trial news does not imply the IBTA’s particular endorsement or not of any trial.

Other websites linked from the IBTA e-News are not under the control of the IBTA. Therefore we take no responsibility for their content. The IBTA has provided these links as a convenience to you and can in no way verify the information, quality, safety or suitability of linked websites.

Any company sponsorship of the IBTA's projects does not imply the IBTA's endorsement of any particular form or forms of therapy, treatment regimen or behaviour. (For further details of our sponsors, please see our Sponsorship Policy).

The views and opinions in the materials included in this e-News may not necessarily be those of the International Brain Tumour Alliance.

unsubscribe from this list update subscription preferences